Vistarin Injection 8000 Anti-Xa IU/0.8 ml contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) widely used for prevention and treatment of blood clots. It functions as an anticoagulant by inhibiting Factor Xa and, to a lesser extent, Factor IIa (thrombin), helping to prevent the formation and extension of thrombi.
This higher-dose pre-filled syringe is ideal for patients requiring therapeutic anticoagulation, including those with moderate to high-risk venous thromboembolism, deep vein thrombosis (DVT), pulmonary embolism (PE), or acute coronary syndromes (ACS). Its pre-measured format ensures accurate dosing, convenience, and patient safety.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Indications
Vistarin Injection 8000 Anti-Xa IU/0.8 ml is indicated for:
-
Prevention of venous thromboembolism (VTE) in high-risk surgical or hospitalized patients
-
Treatment of deep vein thrombosis (DVT) with or without pulmonary embolism (PE)
-
Management of acute coronary syndromes (ACS) to prevent further thrombus formation
-
Therapeutic anticoagulation for patients requiring weight-based dosing or higher anti-Xa activity
Mechanism of Action
Enoxaparin Sodium works by:
-
Binding to antithrombin III, enhancing its inhibition of Factor Xa and partially Factor IIa (thrombin)
-
Preventing clot formation and propagation in the venous and arterial circulation
-
Providing predictable anticoagulant activity with lower risk of heparin-induced thrombocytopenia (HIT) compared to unfractionated heparin
-
Reducing the risk of venous and arterial thromboembolic events in patients with cardiovascular or thrombotic disorders
Dosage and Administration
-
Administer via subcutaneous injection, typically in the abdomen
-
Pre-filled syringe ensures accurate dosing of 8000 Anti-Xa IU/0.8 ml
-
Dosage frequency and duration are determined by the patient’s clinical condition, body weight, and physician guidance
-
Avoid intramuscular injections to reduce the risk of hematoma
-
Rotate injection sites to prevent skin irritation
-
Regular monitoring of platelet count, renal function, and signs of bleeding is recommended
Benefits
-
Prevents venous thromboembolism and pulmonary embolism in high-risk patients
-
Effectively treats deep vein thrombosis and acute coronary syndromes
-
Predictable anticoagulant effect reduces the need for frequent laboratory monitoring
-
Lower incidence of heparin-induced thrombocytopenia (HIT) than standard heparin
-
Pre-filled syringe ensures convenient, accurate, and safe administration
Side Effects
Common side effects may include:
-
Mild injection site reactions (pain, redness, swelling)
-
Minor bruising or bleeding
Serious but rare side effects:
-
Severe internal or gastrointestinal bleeding
-
Heparin-induced thrombocytopenia (HIT)
-
Allergic reactions, including rash, swelling, or difficulty breathing
Seek immediate medical attention if severe bleeding or allergic reactions occur.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Precautions and Warnings
-
Use cautiously in patients with active bleeding, severe renal or hepatic impairment, or thrombocytopenia
-
Avoid concurrent use with other anticoagulants or antiplatelet drugs unless prescribed
-
Pregnancy and breastfeeding: use only under strict medical supervision
-
Regular monitoring of blood counts and coagulation parameters is advised
-
Contraindicated in patients with a history of heparin-induced thrombocytopenia (HIT)
Storage
-
Store at 2°C to 8°C (refrigerated)
-
Protect from light and freezing
-
Keep the syringe in its original packaging until use
-
Keep out of reach of children
-
Do not use after the expiration date.